Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Sponsor: Novartis Pharmaceuticals
Summary
The purpose of this study is to provide efficacy and safety data for remibrutinib in patients with secondary progressive multiple sclerosis (SPMS)
Official title: A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Remibrutinib in Patients With Secondary Progressive Multiple Sclerosis
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
1275
Start Date
2025-11-11
Completion Date
2034-01-02
Last Updated
2026-04-06
Healthy Volunteers
No
Interventions
Remibrutinib (blinded)
Remibrutinib (Blinded) active treatment, oral tablet
Placebo
Matching placebo (binded), oral tablet
Remibrutinib (Open label)
Remibrutinib (Open Label), oral tablet
Locations (90)
Alabama Neurology Associates PC
Birmingham, Alabama, United States
AZ Integrated Neuro and Spine
Phoenix, Arizona, United States
Center for Neurosciences
Tucson, Arizona, United States
Fullerton Neuro and Headache Ctr
Fullerton, California, United States
Regina Berkovich MD PhD Inc
West Hollywood, California, United States
Georgetown University Hospital
Washington D.C., District of Columbia, United States
Neurology of Central FL Res Ctr
Altamonte Springs, Florida, United States
UF Health Cancer Center
Gainesville, Florida, United States
Aqualane Clinical Research
Naples, Florida, United States
Orlando Health Clinical Trials
Orlando, Florida, United States
Comprehensive Neurology Clinic
Orlando, Florida, United States
Neurology Associates of Ormond Beach
Ormond Beach, Florida, United States
Axiom Brain Health
Tampa, Florida, United States
Hawaii Pacific Neuroscience LLC
Honolulu, Hawaii, United States
University of Kansas Hospital
Kansas City, Kansas, United States
Mid Atlantic Epilepsy and Sleep Ctr
Bethesda, Maryland, United States
Michigan Institute of Neurological
Farmington Hills, Michigan, United States
Neurology Clinic PC
Cordova, Tennessee, United States
Saturn Research Solution
Plano, Texas, United States
Novartis Investigative Site
Buenos Aires, Argentina
Novartis Investigative Site
Caba, Argentina
Novartis Investigative Site
Santiago del Estero, Argentina
Novartis Investigative Site
Kogarah, New South Wales, Australia
Novartis Investigative Site
New Lambton Heights, New South Wales, Australia
Novartis Investigative Site
Westmead, New South Wales, Australia
Novartis Investigative Site
Clayton, Victoria, Australia
Novartis Investigative Site
Heidelberg, Victoria, Australia
Novartis Investigative Site
Pleven, Bulgaria
Novartis Investigative Site
Sofia, Bulgaria
Novartis Investigative Site
Sofia, Bulgaria
Novartis Investigative Site
Sofia, Bulgaria
Novartis Investigative Site
Vancouver, British Columbia, Canada
Novartis Investigative Site
Lévis, Quebec, Canada
Novartis Investigative Site
Montreal, Quebec, Canada
Novartis Investigative Site
Montreal, Quebec, Canada
Novartis Investigative Site
Montreal, Quebec, Canada
Novartis Investigative Site
Sherbrooke, Quebec, Canada
Novartis Investigative Site
Wuhan, Hubei, China
Novartis Investigative Site
Hohhot, Inner Mongolia, China
Novartis Investigative Site
Suzhou, Jiangsu, China
Novartis Investigative Site
Hangzhou, Zhejiang, China
Novartis Investigative Site
Wenzhou, Zhejiang, China
Novartis Investigative Site
Chongqing, China
Novartis Investigative Site
Shanghai, China
Novartis Investigative Site
Tianjin, China
Novartis Investigative Site
Medellín, Colombia
Novartis Investigative Site
Medellín, Colombia
Novartis Investigative Site
Jihlava, Czechia
Novartis Investigative Site
Ajaccio, France
Novartis Investigative Site
Amiens, France
Novartis Investigative Site
Clermont-Ferrand, France
Novartis Investigative Site
Gonesse, France
Novartis Investigative Site
Grenoble, France
Novartis Investigative Site
Lille, France
Novartis Investigative Site
Lille, France
Novartis Investigative Site
Montpellier, France
Novartis Investigative Site
Nice, France
Novartis Investigative Site
Nîmes, France
Novartis Investigative Site
Paris, France
Novartis Investigative Site
Poitiers, France
Novartis Investigative Site
Tours, France
Novartis Investigative Site
Freiburg im Breisgau, Baden-Wurttemberg, Germany
Novartis Investigative Site
Halle, Saxony-Anhalt, Germany
Novartis Investigative Site
Budapest, Hungary
Novartis Investigative Site
Kistarcsa, Hungary
Novartis Investigative Site
Gurugram, Haryana, India
Novartis Investigative Site
Mangalore, Karnataka, India
Novartis Investigative Site
Kochi, Kerala, India
Novartis Investigative Site
New Delhi, National Capital Territory of Delhi, India
Novartis Investigative Site
Vellore, Tamil Nadu, India
Novartis Investigative Site
Hyderabad, Telangana, India
Novartis Investigative Site
Jerusalem, Israel
Novartis Investigative Site
Ramat Gan, Israel
Novartis Investigative Site
Rehovot, Israel
Novartis Investigative Site
Tel Aviv, Israel
Novartis Investigative Site
Ẕerifin, Israel
Novartis Investigative Site
Foggia, FG, Italy
Novartis Investigative Site
Braga, Portugal
Novartis Investigative Site
Lisbon, Portugal
Novartis Investigative Site
Bucharest, Romania
Novartis Investigative Site
Campulung Muscel, Romania
Novartis Investigative Site
Cape Town, Western Cape, South Africa
Novartis Investigative Site
L'Hospitalet de Llobregat, Barcelona, Spain
Novartis Investigative Site
Valencia, Valencia, Spain
Novartis Investigative Site
Barcelona, Spain
Novartis Investigative Site
Málaga, Spain
Novartis Investigative Site
Salamanca, Spain
Novartis Investigative Site
Bern, Switzerland
Novartis Investigative Site
Lausanne, Switzerland
Novartis Investigative Site
Glasgow, United Kingdom